Mar. 27, 2020 - Disruptions to businesses in Canada and across the globe as the COVID-19 public health crisis continues to unfold are raising a variety of competition law issues that will need to be managed in responding to challenges and opportunities associated with the ongoing pandemic. We highlight some of...
Bayer AG Acquires Monsanto Company for US$63 Billion
Davies acted for Monsanto Company with respect to Canadian regulatory matters in its approximately US$63 billion acquisition by Bayer AG.
The merger, which will form a global leader in agriculture, faced extensive regulatory reviews internationally and in Canada. To address concerns about the competitive impact of the proposed transaction in Canada, the Commissioner of Competition and Bayer AG entered into a Consent Agreement requiring Bayer to divest its canola seeds and traits business, as well as its soybean seeds and traits business, its carrot seeds business and a seed treatment business.
Davies’ Competition, Antitrust & Foreign Investment team is frequently retained to provide its expertise in the most complex and high-profile Canadian and multinational mergers. The team on this transaction included John Bodrug, Elisa Kearney and Alysha Manji-Knight.
Mar. 20, 2020 - The Canadian Competition Bureau and the Canadian Competition Tribunal have each issued public statements outlining how the COVID-19 pandemic is affecting their respective operations. While the Bureau remains open for business, with staff operating remotely where possible, the Bureau acknowledges...